Medidat SPRL
Medidat reported total assets of 57,897 € at the end of the 2025 financial year (annual accounts filed with the NBB on 13 Oct 2026).
The score of Medidat shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -52 % Total assets -55 %
Accounts of the company itself (not consolidated).
The full file covers 14 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medidat's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Oct 2026
- Year ended 31 Dec 2024filed on 24 Sep 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 01 Sep 2023
- Year ended 31 Dec 2021filed on 11 Jul 2022
Medidat's financial analysis
- Solvency75.0%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medidat
Medidat's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0428.034.076
- VAT number
- BE0428034076
- Peppol
- Registered · 0208:0428034076 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 18 Nov 1985
- Registered office
- 2610 Antwerp
- Latest accounts
- 2025 · filed on 13 Oct 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Medidat (SPRL) has been based in Antwerp since 1985, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 1,007 € and equity of 43,444 €; its revenue is not published. Its solvency stands at 75.0%, above the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Medidat
Companies in the same business, of comparable size and area, outside its group.
- Medicode Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 63,460 €
- Eurohistocyt Wholesale of pharmaceutical and medical goods Beveren-Kruibeke-Zwijndrecht · balance sheet 73,853 €
- Globex International Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 92,829 €
- Lopital België Wholesale of pharmaceutical and medical goods Aartselaar · balance sheet 120,231 €
- PharmSync Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 136,689 €
- Imtec Diagnostics Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 141,739 €
- NBS Scientific Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 152,659 €
- BVPM Distribution Andenne · balance sheet 20,739 €
Frequently asked questions about Medidat
What is the revenue of Medidat?
Medidat files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medidat?
In Belgium, the VAT number is the company number prefixed with BE: BE0428034076 for Medidat, if the company is VAT-registered. Its company number (CBE) is 0428.034.076.
Where is the registered office of Medidat?
According to the CBE register, the registered office of Medidat is in 2610 Antwerp.
What is the equity of Medidat?
At the close of the 2025 financial year, the equity of Medidat amounts to 43,444 €, a solvency of 75.0% of total assets.
Who manages Medidat?
The register lists 1 active mandates at Medidat. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medidat
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →